Stand-alone XLIF: 22 consecutive patients with degenerative scoliosis and foraminal stenosis in a 2-year follow-up
More details
Hide details
Sector for Spine Surgery and Research, Middelfart Hospital, Denmark
Emil Jesper Hansen   

Sector for Spine Surgery and Research, Middelfart Hospital, Østre Hougvej 55, Middelfart 5500, Denmark. Tel.: +45 22 13 67 20; fax: +45 63 48 42 81.
Submission date: 2014-09-02
Acceptance date: 2015-03-09
Online publication date: 2015-04-20
Publication date: 2020-03-24
Pol. Ann. Med. 2015;22(1):1–4
Adult thoracolumbar degeneration is an increasing challenge in the aging population. With age the progressive degeneration of the discs leads to an asymmetric collapse and a thoracolumbar coronal plane deformity, a degenerative scoliosis (DS).

To evaluate the complication rate and clinical/radiological results in 22 patients treated with XLIF procedure for DS or degenerative disc disease (DDD).

Material and methods:
22 consecutive patients with DS underwent surgery with the XLIF stand-alone procedure, with follow-up of 24 months. Clinical outcome scores were collected. Complications were recorded.

Results and discussion:
22 patients, mean age of 65 years (48–81), underwent surgery on 49 levels (1–4) between L1 and L5. VAS for leg pain improved from 5.94 to 3.5 (P < 0.05) and back pain from 5.91 to 3.7 (P < 0.05). EQ 5D-3L improved from 0.29 to 0.62 (P < 0.05). Seven patients (31.8%) underwent revision surgery. Fusion was achieved in 53% (25/49) at 1-year follow-up. Anterior thigh pain was reported in 12 patients postoperatively, and in 2 patients at 1-year follow-up.

The XLIF stand-alone procedure improves clinical outcome scores significantly after 1- and 2-year follow-up, with a 31.8% revision rate. Due to the high revision rate we recommend supplementary posterior instrumentation, to achieve a higher fusion rate. When considering XLIF-stand-alone procedure for DS or DDD without supplemental posterior instrumentation, only single-level disease should be advised, taking sagittal parameters into account.

None declared.
Oskouian Jr RJ, Shaffrey Cl. Degenerative lumbar scoliosis. Neurosurg Clin N Am. 2006;17:299–315.
Watanuki A, Yamata H, Tsutsui T, En-yo Y, Yoshida M, Yoshimura N. Radiographic features and risk of curve progression of de-novo degenerative lumbar scoliosis in the elderly: a 15 year follow-up study in a community-based cohort. J Orthop Sci. 2012;17(5):526–531.
Deluzio KJ, Lucio JC, Rodgers WB. Value and cost in less invasive spinal fusion surgery: lessons from a community hospital. SAS J. 2010;4:37–40.
Ozgur BM, Aryan HE, Pigmenta L, Taylor WR. Extreme lateral interbody fusion (XLIF): a novel surgical technique for anterior lumbar interbody fusion. Spine J. 2006;6:435–443.
Isaacs RE, Hyde J, Goodrich JA, Rodgers WB, Phillips FM. A prospective, nonrandomized, multicenter evaluation of extreme lateral interbody fusion for the treatment of adult degenerative scoliosis. Spine J. 2010;35(Suppl. 26):S322–S330.
Phillips FM, Isaacs R, Rodgers WB, et al. Adult degenerative scoliosis treated with XLIF. Spine J. 2013;38:1853–1861.
Fujita T, Kostuik JB, Huckell CB, Sieber AN. Complications of spinal fusion in adult patients more than 60 years of age. Orthop Clin North Am. 1998;29:669–678.
Nemani VM, Aichmar A, Taher F, et al. Rate of revision surgery after stand-alone lateral lumbar interbody fusion for lumbar spinal stenosis. Spine J. 2014;39(5):E226–E331.
Rogers WB, Gerber EJ, Patterson BA. Intraoperative and early postoperative complications in extreme lateral interbody fusion. Spine J. 2010;36:26–33.
Yamada K, Matsuda H, Nabeta M, Habunaga H, Suzuki A, Nakamura H. Clinical outcomes of microscopic decompression for degenerative lumbar foraminal stenosis: a comparison between patients with and without degenerative lumbar scoliosis. Eur Spine J. 2010;20(6):947–953.
Malham G, Ellis NJ, Parker RM, Seex KA. Clinical outcome and fusion rates after the first 30 extreme lateral interbody fusions. ScientificWorldJournal. 2012;246989.
Lykissas MG, Aichmair A, Sama AA, et al. Nerve injury and recovery after lateral interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study. Spine J. 2014;14:217–224.